PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Jun-2023 Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023 Vitruvia Medical AG
23-Jun-2023 Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East Relief Therapeutics Holding SA
23-Jun-2023 RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement Relief Therapeutics Holding SA
22-Jun-2023 Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis Imcyse
22-Jun-2023 EDX MEDICAL GROUP PLC STRENGTHENS SENIOR TEAM EDX MEDICAL GROUP PLC
22-Jun-2023 Real-world study from Koa Health finds context is key factor in how smartphone use impacts wellbeing Koa Health
22-Jun-2023 Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharmaceuticals to Develop a Novel Cancer Therapeutic Lubrizol Life Science, Health
22-Jun-2023 Genomic Vision Enters Distribution Agreement with CliniSciences B3C newswire
22-Jun-2023 Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea Cosmo Pharmaceuticals N.V.
21-Jun-2023 Marinomed Biotech AG: Annual General Meeting elects Dr. Eva Hofstädter-Thalmann as a new member of the Supervisory Board Marinomed Biotech AG
21-Jun-2023 Medios AG: Annual General Meeting re-elects Dr. Yann Samson, Joachim Messner and Klaus J. Buß to the Supervisory Board Medios AG
21-Jun-2023 Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical Telix Pharmaceuticals Limited
21-Jun-2023 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
21-Jun-2023 Board Change BenevolentAI
21-Jun-2023 FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) QIAGEN
20-Jun-2023 Media Release Zurich, June 20, 2023   Xlife Sciences: shareholders approved all motions at today’s AGM 2023 Xlife Sciences AG
20-Jun-2023 Evotec SE Annual General Meeting 2023 approves all proposed agenda items Evotec SE
20-Jun-2023 CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma CureVac
20-Jun-2023 CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board CureVac
20-Jun-2023 NEW THEALIPID® EYE DROPS FROM THÉA PROVIDE LONG-LASTING SYMPTOM RELIEF OF DRY EYE THÉA